Relapsed Acute Lymphoblastic Leukemia (ALL) Active Not Recruiting Phase 1 / 2 Trials for Methotrexate (DB00563)

Back to Relapsed Acute Lymphoblastic Leukemia (ALL)

Also known as: Acute Lymphoblastic Leukemia, in Relapse / Relapsed ALL / Relapsed Acute Lymphoblastic Leukemia / Acute, relapsed Lymphoblastic Leukemia

Indication	Status	Phase
DBCOND0069491 (Relapsed Acute Lymphoblastic Leukemia (ALL))	Active Not Recruiting	1 / 2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT05192889	Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax	Treatment	Asparaginase Erwinia chrysanthemi (DB08886) Asparaginase Escherichia coli (DB00023) Blinatumomab (DB09052) Calaspargase pegol (DB14730) Cyclophosphamide (DB00531) Cytarabine (DB00987) Dasatinib (DB01254) Dexamethasone (DB01234) Etoposide (DB00773) Hydrocortisone (DB00741) Leucovorin (DB00650) Mercaptopurine (DB01033) Methotrexate (DB00563) Navitoclax (DB12340) Pegaspargase (DB00059) Venetoclax (DB11581) Vincristine (DB00541)